News

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.
A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly ...
Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...
According to Coherent Market Insights (CMI), the global sickle cell disease treatment market size is expected to expand from USD 3.20 Bn in 2025 to USD 8.81 Bn by 2032, recording a CAGR of 15.6% ...
It has been nearly two years since Pfizer’s sickle cell disease (SCD) therapy Oxbryta was approved in the UK, but patients will now be able to access the treatment after an agreement was reached ...
Hemoglobinopathies Market The hemoglobinopathies market is advancing rapidly, driven by gene therapy, new drugs, and rising access for trea ...
So far in 2025, the Trump administration has cut more than $1 billion in NIH grants. That includes a study on sickle cell ...
Families of those who have sickle cell disease in the Philadelphia area are pushing for more research and a cure.
CMS has reached agreements with drug manufacturers to provide gene therapies to treat sickle cell disease to Medicaid recipients under a new outcomes-based model. A total of 33 states, including the ...
Over a hundred sickle cell warriors and their families turned out in support for World Sickle Cell Day at West Oakland’s DeFremery Park on Sunday.
Sickle cell disease, a rare genetic blood disorder, affects over 1,700 people in Indiana, including Kyle Law and his mother.